Global Airway Management Devices Patent Landscape Report 2024

Global Airway Management Devices Market Size

The global airway management devices market was valued at USD 2.56 billion in 2023. It is expected to grow at a CAGR of 5.9% during the forecast period of 2024-2032 and attain a market value of USD 4.29 billion by 2032.

The market growth is driven by the increasing prevalence of respiratory diseases. Patents are focused on advanced technologies such as infraglottic airway management and supraglottic airway management among airway management devices.

Patent Landscape Report Coverage

The Global Airway Management Devices Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for airway management devices include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with airway management devices. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within airway management device technologies.

Key Inclusions

• Patent Valuation Analysis

A valuation analysis and competitive benchmarking of key members of unique patent families are covered in the analysis for airway management devices technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with airway management devices.

• Analysis of Patent Applications

A comprehensive summary of several patent applications which were filed across different jurisdictions for airway management devices and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.

• Analysis of Granted Patents

Detailed analysis of the granted patents across different jurisdictions for airway management devices and their relative value in the IP are covered in the final report.

Airway Management Devices Patent Outlook

• Demand for effective airway management solutions is increased by the increased prevalence of respiratory conditions like asthma, sleep apnea, and chronic obstructive pulmonary disease (COPD), which calls for these solutions.

• The need for airway management devices in both emergency and long-term care settings is growing as the world's population ages and becomes more susceptible to respiratory and cardiovascular diseases.

• To maintain patient safety and adequate ventilation during procedures, there is an increasing need for airway management devices due to the rise in surgical procedures, especially those involving general anesthesia.

What are Airway Management Devices?

Airway management devices are used to make sure that a patient's airway is open and clear so that adequate ventilation, oxygenation, and breathing can occur. Laryngeal masks, endotracheal tubes, and other instruments intended for use in critical care, emergency, and surgical settings are among these devices.

The components of airway management devices include infraglottic airway management devices, supraglottic airway management devices, laryngoscopes, resuscitators, and others. Infraglottic airway management devices are used to maintain the airway by inserting endotracheal or tracheostomy tubes through the vocal cords and into the trachea. These devices, which are frequently used in emergency, intensive care, and surgical settings, guarantee direct and controlled ventilation.

Airway Management Devices Industry Growth Drivers

Advancements in Airway Management Technologies is Expected to Boost the Patent Industry Growth

There is an increase in patent activity which focuses on enhancing the performance of airway management devices. There were 1,001 patents granted in 2022 and by 2023 around 1,065 patents were granted. The development of portable ventilators and video laryngoscopes, among other innovations in airway management technologies, has improved the efficacy, safety, and precision of airway management techniques. They propel market growth as these innovations give medical professionals more dependable and effective tools for patient care. For instance, the Philips Ventilator BiPAP A40 EFL has expanded its range of homecare solutions with the launch of this non-invasive ventilator, which offers a new ventilation therapy feature to help patients with chronic obstructive pulmonary disease (COPD) breathe more easily.

Patents covering these technologies are crucial for companies and thus impact the airway management devices' patent landscape.

Rising Number of Surgical Procedures is Expected to Propel Airway Management Devices Patent Industry

To maintain patient safety and adequate ventilation during procedures, there is an increasing need for airway management devices due to the rise in surgical procedures, especially those involving general anesthesia.

Airway Management Devices Patent Segmentation

The report will cover the following sections in detail:

Analysis by Type

• Infraglottic Airway Management Devices
  • Endotracheal Tubes
  • Tracheostomy Tubes

• Supraglottic Airway Management Devices
  • Laryngeal Mask Airways
  • Oropharyngeal Mask Airways
  • Nasopharyngeal Mask Airways
  • Others

• Laryngoscopes

• Resuscitators

• Others

Analysis by Application

• Anaesthesia

• Emergency Medicine

• Others

Airway Management Devices Patent Segmentation Analysis

The breakup based on type includes infraglottic airway management devices, supraglottic airway management devices, laryngoscopes, resuscitators, and others. Supraglottic airway management devices are used to keep a patient's airway open while under anaesthesia or in an emergency by positioning themselves above the vocal cords. These devices, like laryngeal masks, offer endotracheal intubation as a less intrusive option.

Airway Management Devices Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for airway management device patents, having around 26,500+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.

Patent Profile of Key Companies

Among the players with airway management device patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the Airway Management devices field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Resmed Pty Ltd

Established in 1989, ResMed Pty Ltd is a company focused on creating and producing cutting-edge devices for managing airways, specifically for sleep apnea and related respiratory disorders. ResMed, a global leader in the supply of cutting-edge medical equipment and cloud-connected solutions to enhance patient outcomes and quality of life, has its headquarters located in San Diego, California.

Bayer Healthcare AG

Bayer HealthCare AG is a division of Bayer AG dedicated to offering cutting-edge pharmaceutical and airway management solutions. Bayer HealthCare AG, which has its headquarters in Leverkusen, Germany, uses cutting-edge technology to enhance patient care and results everywhere. It was founded in 2006.

Other companies include Alfen Medical Devices Dev Ltd, Alphin Medical Products Inc, Shenzhen Yinsaidesi Medical Technology Co Ltd, Alnylam Pharmaceuticals Inc, Honeywell Int INC, Cardiac Pacemakers INC, Covidien Lp, and Koninklijke Philips NV, among others.

Reasons to Purchase this Report

The Airway Management Devices patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and makes it understandable which companies have important patents in this field of airway management devices.

• Innovation Insights: The patent analysis reveals new innovations and technologies in airway management devices.

• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry within the airway management device patent landscape.

• Risk Assessment: In technology-intensive fields such as airway management devices, risks of IP infringement are common. Analyzing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

Key Questions Answered in the Airway Management Devices Patent Landscape Report 

• Who are the key players in the airway management devices patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in airway management device patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the airway management devices industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in airway management devices?
• What are the challenges and opportunities in the airway management devices patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in airway management devices?

Related Reports

Upper Respiratory Tract Infection Treatment Market

Respiratory Gas Monitors Market

Respiratory Care Device Market